Search

Learn how a novel drug is showing promise against lung and pancreatic cancer in early clinical trials by targeting the KRAS G12D mutation with a KRAS degrader.

New research from Memorial Sloan Kettering highlighted in advance of the 50th Annual Meeting of the American Society of Clinical Oncology demonstrates the powerful clinical benefit of giving patients a drug that targets the molecular abnormality driving the growth of advanced pigmented villonodular synovitis, a rare and debilitating joint disease.

As America commemorates the 50th anniversary of the “War on Cancer,” MSK addresses the question “Where do we go from here?”

There are new, FDA-authorized treatment options for people facing esophageal and gastric (stomach) cancer, thanks to clinical trials at Memorial Sloan Kettering that combined immunotherapy with standard treatments.

Researchers at Memorial Sloan Kettering (MSK) report today in the New England Journal of Medicine that adult patients with acute lymphoblastic leukemia (ALL) who received chimeric antigen receptor (CAR) T cell therapy responded better if they had a small amount of disease at the time of the treatment. Compared with patients with a greater amount of disease, those in the low-disease category lived significantly longer and experienced fewer life-threatening side effects.  

Learn about the difference methods of colorectal cancer screening, including the at-home Cologuard test, from an expert at Memorial Sloan Kettering Cancer Center.

Obtenga información sobre los diferentes métodos de detección de cáncer colorrectal, incluso la prueba casera Cologuard, de una experta de Memorial Sloan Kettering Cancer Center.

Узнайте о способах обследования на наличие рака толстой и прямой кишки, в том числе о домашнем анализе Cologuard, у специалиста Memorial Sloan Kettering Cancer Center.